Burkholderia cenocepacia and Salmonella enterica ArnT proteins that transfer 4-amino-4-deoxy-L-arabinose to lipopolysaccharide share membrane topology and functional amino acids by Tavares-Carreón, Faviola et al.
Burkholderia cenocepacia and Salmonella enterica ArnT proteins
that transfer 4-amino-4-deoxy-L-arabinose to lipopolysaccharide
share membrane topology and functional amino acids
Tavares-Carreón, F., Patel, K. B., & Valvano, M. A. (2015). Burkholderia cenocepacia and Salmonella enterica
ArnT proteins that transfer 4-amino-4-deoxy-L-arabinose to lipopolysaccharide share membrane topology and
functional amino acids. Scientific Reports, 5, [10773]. DOI: 10.1038/srep10773
Published in:
Scientific Reports
Document Version:
Publisher's PDF, also known as Version of record
Queen's University Belfast - Research Portal:
Link to publication record in Queen's University Belfast Research Portal
Publisher rights
Copyright 2015 The Authors
This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article
are included in the article’s Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the
Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this
license, visit http://creativecommons.org/licenses/by/4.0/
General rights
Copyright for the publications made accessible via the Queen's University Belfast Research Portal is retained by the author(s) and / or other
copyright owners and it is a condition of accessing these publications that users recognise and abide by the legal requirements associated
with these rights.
Take down policy
The Research Portal is Queen's institutional repository that provides access to Queen's research output. Every effort has been made to
ensure that content in the Research Portal does not infringe any person's rights, or applicable UK laws. If you discover content in the
Research Portal that you believe breaches copyright or violates any law, please contact openaccess@qub.ac.uk.
Download date:15. Feb. 2017
1Scientific RepoRts | 5:10773 | DOi: 10.1038/srep10773
www.nature.com/scientificreports
Burkholderia cenocepacia and 
Salmonella enterica ArnT proteins 
that transfer 4-amino-4-deoxy-l-
arabinose to lipopolysaccharide 
share membrane topology and 
functional amino acids
Faviola Tavares-Carreón1, Kinnari B. Patel2 & Miguel A. Valvano1,2
We recently demonstrated that incorporation of 4-amino-4-deoxy-l-arabinose (l-Ara4N) to the 
lipid A moiety of lipopolysaccharide (LPS) is required for transport of LPS to the outer membrane 
and viability of the Gram-negative bacterium Burkholderia cenocepacia. ArnT is a membrane 
protein catalyzing the transfer of l-Ara4N to the LPS molecule at the periplasmic face of the inner 
membrane, but its topology and mechanism of action are not well characterized. Here, we elucidate 
the topology of ArnT and identify key amino acids that likely contribute to its enzymatic function. 
PEGylation assays using a cysteineless version of ArnT support a model of 13 transmembrane helices 
and a large C-terminal region exposed to the periplasm. The same topological configuration is 
proposed for the Salmonella enterica serovar Typhimurium ArnT. Four highly conserved periplasmic 
residues in B. cenocepacia ArnT, tyrosine-43, lysine-69, arginine-254 and glutamic acid-493, were 
required for activity. Tyrosine-43 and lysine-69 span two highly conserved motifs, 42RYA44 and 
66YFEKP70, that are found in ArnT homologues from other species. The same residues in S. enterica 
ArnT are also needed for function. We propose these aromatic and charged amino acids participate in 
either undecaprenyl phosphate-l-Ara4N substrate recognition or transfer of l-Ara4N to the LPS.
The Gram-negative opportunistic bacterium Burkholderia cenocepacia causes serious lung infections in 
patients with cystic fibrosis1,2. B. cenocepacia is difficult to treat because of its extraordinarily high intrin-
sic resistance to virtually all clinically useful antibiotics including antimicrobial peptides such as the 
polymyxins3–5. Intrinsic resistance of B. cenocepacia depends in part on its lipopolysaccharide (LPS)6–8. B. 
cenocepacia can modify its LPS lipid A moiety by incorporating 4-amino-4-deoxy-l-arabinose (l-Ara4N). 
The LPS inner core oligosaccharide contains a side branch d-glycero-d-talo-octo-2-ulosonic acid, which 
is also modified by l-Ara4N9,10. These modifications neutralize negative charges in the LPS molecule, 
inhibiting binding of cationic molecules11. Remarkably, l-Ara4N modification in B. cenocepacia is essen-
tial for bacterial viability12, since it is required for LPS export to the outer membrane13, and for high 
resistance to polymyxin B (PmB) at concentrations reaching milligram range4,7,8,13,14.
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l-Ara4N biosynthesis occurs in the cytoplasm by the enzymes AraABCD. This process converts 
UDP-glucuronic acid into l-Ara4N linked to undecaprenyl phosphate15. Undecaprenyl phosphate-l-Ara4N 
is translocated across the inner membrane by the heterodimer ArnE-ArnF flippase16 and finally ArnT 
transfers l-Ara4N to the lipid A in a reaction occurring at the periplasmic face of the inner mem-
brane17. Hamad et al.13 postulated that B. cenocepacia ArnT also transfers l-Ara4N to the inner core 
d-glycero-d-talo-octo-2-ulopyranosoic acid, but this was not directly demonstrated. Because the transfer 
of l-Ara4N to the LPS is essential for B. cenocepacia viability12,13, ∆arnT mutants are only viable if a 
suppressor mutation occurs in the lptG gene encoding a component of the LPS transport pathway, which 
allows export of unmodified LPS13.
Lipid A modifications requiring ArnT family proteins have been reported in Escherichia coli, Salmonella 
enterica serovar Typhimurium and Pseudomonas aeruginosa where LPS is modified with l-Ara4N18,19, 
and in Francisella novicida and two Bordetella species (B. bronchiseptica and B. pertussis) where LPS is 
modified with galactosamine and glucosamine, respectively20–22. Since LPS modifications contribute to 
pathogenicity and innate immunity evasion, ArnT can be considered a virulence factor in these bacteria.
ArnT is an integral membrane protein; its topology was partially characterized in S. enterica23, but 
little is known on functional regions and enzyme mechanism. Elucidating the topology of ArnT is criti-
cal to understand its function and developing molecules targeting l-Ara4N modification of LPS, which 
would abolish intrinsic bacterial resistance to antimicrobial peptides. In this study, we characterize the 
topology of B. cenocepacia and S. enterica ArnT. Both proteins show very similar topology, suggesting 
the topological arrangement in other proteins of the ArnT family is likely conserved. We propose ArnT 
proteins consist of thirteen transmembrane domains with two large periplasmic loops and a C-terminal 
segment that is exposed to the periplasm. We also identify four highly conserved periplasmic amino 
acids that are presumably involved in ArnT function.
Results
ArnT is a membrane protein with 13 predicted transmembrane helices. To facilitate immuno-
detection while exploring the ArnT topology we constructed a recombinant protein carrying a C-terminal 
FLAG-10xHis tag. ArnTFLAG-10xHis was expressed under the control of a rhamnose-inducible promoter in 
the ∆arnT-arnBC+lptGD31H suppressor strain (herein ∆arnT)13. This B. cenocepacia strain is viable but 
highly sensitive to PmB due to lack of l-Ara4N in the LPS13. In the presence of rhamnose, ArnTFLAG-10xHis 
restored ∆arnT PmB resistance to parental levels (Supplementary Figure S1A online), and was detected 
by immunoblot as a polypeptide with an apparent mass of 63 kDa, in agreement with its predicted mass 
of 66.3 kDa (Supplementary Figure S1B online). These experiments demonstrate that the FLAG-10xHis 
tag does not affect ArnT function and membrane localization.
Earlier work suggested that S. enterica and E. coli ArnT proteins contain 12 predicted transmem-
brane helices and that the C-terminus is in the cytosolic compartment17,23. However, an in silico model 
of B. cenocepacia ArnT topology with PolyPhobius predicted 13 transmembrane helices and a large 
C-terminus exposed to the periplasmic space in both S. enterica and E. coli ArnT proteins (Fig. 1). To 
provide experimental evidence for the predicted ArnT transmembrane topology we used the substi-
tuted cysteine accessibility method with methoxypolyethylene glycol maleimide (PEG-mal) labeling24,25. 
PEG-mal is a maleimide conjugate that modifies cysteines but cannot cross membranes. Reaction of a 
cysteine with PEG-mal results in a mass addition of ~5 kDa to the protein, which appears as a band 
shift by immunoblotting. PEG-mal modification using EDTA-permeabilized whole cells indicates that 
the cysteine has a periplasmic orientation, while PEG-mal modification under denaturing conditions 
(presence of SDS) suggests that the cysteine is within a transmembrane helix or faces the cytoplasm. B. 
cenocepacia ArnTFLAG-10xHis has two cysteine residues at positions 154 and 176, which were replaced by 
alanine to generate a cysteineless derivative (ArnTCysless). ArnTCysless and the single cysteine replacement 
derivatives (ArnTC154A and ArnTC176A) restored PmB resistance in ∆arnT at similar levels as the wild 
type strain (Fig. 2A), demonstrating that the native cysteines are dispensable for ArnT function. Using 
PEG-mal labeling, we observed that ArnTC154A and ArnTC176A were only PEGylated in detergent (2% 
SDS), while ArnTCysless was not PEGylated under any condition (Fig. 2B). These results suggest that Cys-
154 and Cys-C176 are buried in transmembrane helices, as predicted by the in silico model (Fig. 1). Cell 
membrane integrity in these experiments was confirmed by co-expressing ArnTC154 and ArnTC176 with 
HA-SoxY, a cytoplasmic protein that is highly PEGylated24. Immunoblotting using anti-HA antibodies 
shows that HA-SoxY was only PEGylated under denaturing conditions (Fig. 2B), demonstrating that the 
bacterial membranes remained intact.
To confirm whether Cys-154 and Cys-176 are indeed buried, PEGylation was performed in the pres-
ence or absence of N-ethylmaleimide (NEM). NEM is a small sulfhydryl-reactive molecule that crosses 
membranes, but cannot react with cysteines embedded within the membrane bilayer26. As a control, we 
used a phenylalanine-247 cysteine replacement mutant, since this residue is predicted to reside in the 
periplasmic side. PEGylation of the resulting protein was examined in samples pretreated with or with-
out NEM, and also with or without SDS. This experiment showed that ArnTF247C could be PEGylated 
in the absence of NEM (Fig. 2C), demonstrating a periplasmic orientation for this residue. In contrast, 
ArnTC154A and ArnTC176A were PEGylated despite treatment with NEM, demonstrating that the single 
cysteine remaining in each protein (Cys-176 in ArnTC154A and Cys-154 in ArnTC176A) is inaccessible to 
NEM modification (Fig. 2D), as would be expected if these residues are buried in the membrane bilayer. 
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These results support the conclusion that the native cysteine residues in ArnT are in a transmembrane 
helix, as predicted by the in silico topological model.
More experimental evidence for the predicted ArnT topology was obtained by introducing 38 novel 
cysteine replacements at various positions of ArnTCysless. As before, mutant proteins were analyzed by 
immunoblotting to confirm that the cysteine substitution did not affect protein stability and mem-
brane location (Supplementary Figure S2 online). Also, the ArnT cysteine replacements restored PmB 
resistance in ∆arnT to wild type levels. We then analyzed the topology of amino acids predicted to 
reside in transmembrane segments. Cysteine residues replacing valine-106, leucine-278, valine-332, and 
threonine-422 resulted in ArnT proteins that could only be PEGylated in SDS irrespective of NEM 
pretreatment (Fig.  2D), indicating that these amino acids are embedded in the membrane bilayer, as 
predicted by the in silico model.
Next, we examined cysteine replacements in leucine-35, tyrosine-43, asparagine-62, lysine-69, 
glycine-87, asparagine-239, phenylalanine-247, arginine-254, glycine-264, arginine-380 and leucine-385. 
All of the resulting proteins could be PEGylated under non-denaturing conditions in whole cells, indi-
cating that these residues are exposed to the periplasm (Fig.  3A). In contrast, proteins with cysteine 
replacements in residues located in predicted periplasmic hinges such as histidine-137, asparagine-139, 
serine-186, lysine-187, serine-321, histidine-322 and lysine-324, only reacted with PEG-mal upon 
SDS treatment (Fig.  3B), suggesting these residues are most likely embedded in the bilayer. However, 
ArnTF138C and ArnTS323C were PEGylated under non-denaturing conditions, indicating that these residues 
are exposed to the periplasm (Fig.  3B). To confirm this assertion we labeled total membrane prepara-
tions with and without NEM pretreatment to differentiate between solvent exposed and lipid bilayer 
buried residues. Membrane preparations containing proteins with cysteine replacements in histidine-137, 
asparagine-139, serine-186, lysine-187, serine-321, histidine-322, and lysine-324 were PEGylated in the 
presence of NEM, indicating that these residues are not solvent-exposed (Fig. 3C); while ArnTF138C and 
ArnTS323C only were PEGylated in the absence of NEM (Fig. 3C), demonstrating a periplasmic orienta-
tion for these residues. The intensity of the PEGylated band varied in some cases such as in ArnTL35C 
139 187 322
323138
161
Figure 1. ArnT topological model. The model was derived using PolyPhobius and displayed with 
TMRPres2D. The ArnT C-terminus is oriented towards the periplasm and the protein has 13 predicted 
transmembrane helices, indicated by rectangles. The residues replaced by cysteine are shown in gray circles. 
Functional residues are indicated by black circle. The endogenous cysteines of ArnT are shown in black 
squares.
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Figure 2. Native cysteines in ArnT are located in transmembrane segments. (a) Cys-less ArnT protein 
remains functional. Complementation of the ∆arnT-arnBC+ suppressor strain transformed with pSCrhaB2 
encoding ArnTCys-less, ArnTC154A, and ArnTC176A. Cells expressing ArnTFLAG-10xHis and the vector pSCrhaB2 
were used as controls. The transformants were spotted on LB supplemented with 0.4% of l-rhamnose 
(Rham) and 10 μ g ml−1 PmB. (b) E. coli DH5α containing a plasmid encoding SoxY was transformed 
with plasmids expressing ArnTCys-less, ArnTC154A and ArnTC176A. Bacteria were grown to mid-exponential 
phase and protein expression induced with 0.2% l-arabinose. Cells were harvest and resuspend in 0.3 ml 
of HEPES/MgCl2 buffer. 0.1 ml of cell suspension was incubated with buffer alone or 1 mM PEG-mal with 
or without 2% SDS for 1h at room temperature. Reactions were quenched with 45 mM DTT, and proteins 
were separated by SDS-PAGE and transferred to nitrocellulose membrane. ArnT derivatives were detected 
with anti-FLAG and SoxY with anti-hemagglutinin serum. (c) For NEM blocking, cells were harvested and 
resuspended in 0.4 ml of HEPES/MgCl2 buffer, then were incubated with 5 mM NEM for 30 min to block 
accessible sulfhydryl groups. The pellet was washed twice with 0.5 ml of ice-cold HEPES/MgCl2 buffer 
and finally was PEGylated as indicated for panel b. (d) Cells were harvested and resuspended in 0.4 ml of 
HEPES/MgCl2 buffer. 0.1 ml of the cell suspension was incubated with 5 mM NEM for 30 min, and then 
was treated with 1 mM PEG-mal and 2% SDS as indicated in panel B. The position of the molecular mass 
marker is indicated to the left, and the position of PEGylated and non-PEGylated protein to the right.
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Figure 3. PEG-mal labeling of periplasmic and cytoplasmic ArnT amino acids. (a, b, and d) E. coli 
DH5α carrying plasmids encoding ArnT cysteine replacements were grown to mid-exponential phase 
and protein expression induced with 0.2% l-arabinose. Cells were harvested and resuspended in 0.3 ml of 
HEPES/MgCl2 buffer. 0.1 ml of cell suspension was incubated with buffer alone or 1 mM PEG-mal with 
or without 2% SDS for 1 h at room temperature. Reactions were quenched with 45 mM DTT, and proteins 
were separated by SDS-PAGE and transferred to nitrocellulose membranes, followed by immunoblot with 
anti-FLAG antibodies. (c) Crude membrane fractions were incubated with buffer alone or pre-treated 
with 5 mM NEM, after that membrane were incubated with 1 mM PEG-mal and 2% SDS for 1 h at room 
temperature. Reactions were quenched with 45 mM DTT. (e) Crude membrane fractions were isolated 
by ultracentrifugation and divided in two aliquots. One aliquot was incubated with buffer alone and the 
other with 1 mM PEG-mal. The reactions were quenched with 45 mM DTT and separated by SDS-PAGE. 
Immunoblot was probed with anti-FLAG antibody.
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or ArnTF138C when examined by PEGylation of whole-cell preparations (Fig.  3A), and ArnTS186C or 
ArnTK187C when examined directly from membrane preparations (Fig. 3C). Because all the ArnT mutant 
proteins are equally expressed, we attributed reduced PEGylation to close proximity of the residue to the 
membrane bilayer border.
Cysteine replacements at phenylalanine-114, arginine-161, tryptophan-209, isoleucine-288, aspartic 
acid-350, and asparagine-411 resulted in proteins that were only PEGylated under prior denaturing con-
ditions (Fig. 3D), suggesting they are on the cytosolic face of the membrane. These residues were also 
PEGylated in membrane preparations (Fig. 3E), as the conditions used for membrane disruption favor 
formation of inverted vesicles allowing exposure of cytoplasmic residues27,28. Collectively, the experimen-
tal results support the in silico predicted ArnT topology.
The C-terminus of B. cenocepacia and S. enterica ArnT proteins resides in the peri-
plasm. According to the in silico topological model, B. cenocepacia ArnT contains an extended 
C-terminal segment located towards the periplasm. To investigate the orientation of the 123-amino acid 
soluble C-terminal region of B. cenocepacia ArnT, we introduced eight cysteine replacements at aspartic 
acid-439, arginine-455, tyrosine-468, histidine-483, glutamic acid-493, tryptophan-512, glutamine-530, 
and arginine-550. The corresponding proteins were PEGylated in whole cells under non-denaturing con-
ditions, demonstrating that these residues are exposed to the periplasm (Fig. 4A). We also constructed a 
version of ArnT that was C-terminally fused to PhoA (FLAGArnTPhoA), a protein probing for periplasmic 
location29, which was expressed in the E. coli ∆phoA CC118 strain. Immunoblotting of total membranes 
with the anti-FLAG antibody revealed a polypeptide band with an apparent mass of 111.6 kDa consistent 
with the FLAGArnTPhoA predicted mass (Fig. 4B). The CC118 strain expressing the fusion protein produced 
400 U of alkaline phosphatase activity (Fig.  4C), which was comparable to that of the positive control 
(CC118 expressing WzxK367-PhoA)30. Together, these experiments strongly support the conclusion that the 
C-terminal region of B. cenocepacia ArnT is oriented towards the periplasm.
In a previous report23, the C-terminal region of the S. enterica ArnT was assigned to the cytosol 
without experimental confirmation and despite that a periplasmic location was predicted in silico. ArnTSe 
has eight native cysteine residues, two of which (C148 and C149) were predicted to be in the second 
periplasmic loop and the remaining six cysteines embedded in transmembrane segments23. Therefore, 
we constructed a double replacement mutant, ArnTC148A-C149A, which was used to further introduce 
novel cysteines in the C-terminal domain without making a complete Cys-less version of ArnTSe. Novel 
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Figure 4. The ArnT C-terminus resides in the periplasmic space. (a) Whole cells from E. coli strain DH5α 
carrying plasmids encoding cysteine-substitution of the C-terminal of ArnT were treated with buffer alone 
or 1 mM PEG-mal with or without 2% SDS for 1 h at room temperature and quenched with 45 mM DTT. 
Proteins were separated by SDS-PAGE and transferred to nitrocellulose membrane for blotting with anti-
FLAG to detected ArnT. (b) Immunoblot of total membranes from E. coli CC118 cells expressing FLAG-ArnT-
PhoA performed with anti-FLAG. L, BLUeye prestained protein ladder. (c) Quantification of PhoA activity in 
CC118 E. coli expressing FLAG-ArnTPhoA. Cells were grown in LB and induced with 0.2% arabinose. Alkaline 
phosphatase activity was determined by measuring the rate of PNPP hydrolysis. pAH01 encodes FLAG-Wzx-
K367-PhoA and pAH1801 encodes FLAG-Wzx-T242-PhoA, which were used as positive and negative controls, 
respectively30. The values represent the mean ± SE from three independent experiments.
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cysteines replaced glutamic acid-438, aspartic acid-469, arginine-506, and glutamine-544 residues. 
Mutant proteins and parental ArnTSe were detectable by immunoblotting (Fig. 5A). PEGylation was per-
formed in whole cells with and without detergent. ArnTE438C, ArnTD469C, ArnTR506C and ArnTQ544C were 
PEGylated in non-denaturing conditions (Fig. 5B). Since all these residues were accessible to PEG-mal 
we concluded that they are exposed to the periplasmic face and not to the cytosolic space as previously 
proposed23. As a control, the cytoplasmic HA-SoxY protein was only PEGylated under SDS treatment 
(Fig. 5B), ruling out loss of cell membrane integrity during whole cell PEGylation. SDS treatment also 
showed PEGylation of the ArnTSe derivatives under denaturing conditions (Fig. 5B, asterisk), as expected 
given that there were six remaining native cysteines in the protein. Importantly, the parental ArnTSe was 
not PEGylated in absence of SDS (Fig. 5B), indicating that cysteines 148 and 149 are not exposed to the 
second periplasmic loop, as it was reported23.
Further, we investigated the location of the ArnTSe C-terminus by constructing a PhoA fusion 
(FLAGArnTSe-PhoA). Immunoblot of total membrane preparations reacted with anti-FLAG (Fig. 5C) iden-
tified a 110.5-kDa-polypeptide band as expected, indicating that ArnTSe is correctly fused to the PhoA 
protein and that is also in the membrane fraction. Lysates of strain CC118 expressing the fusion protein 
displayed 350 U of alkaline phosphatase activity (Fig.  5D), which was comparable to the activity of 
the positive control cell lysates from CC118 expressing WzxK367-PhoA30. Therefore, the ArnTSe C-terminal 
domain is exposed towards the periplasm, as in ArnTBc.
Identification of functional amino acids in ArnT. We examined the functionality of ArnTBc 
cysteine replacement mutants by determining their ability to restore PmB resistance when expressed 
in the B. cenocepacia ∆arnT lptG suppressor mutant (Supplementary Table S1 online). Only proteins 
with replacements at tyrosine-43, lysine-69, arginine-254, and glutamic acid-493 residues, all of which 
are exposed to the periplasmic space (Fig. 1), failed to complement PmB resistance. Multiple sequence 
alignment revealed that tyrosine-43, lysine-69 (first periplasmic loop), arginine-254 (second periplasmic 
loop), and glutamic acid-493 (C-terminal segment) residues are highly conserved in ArnT proteins from 
different bacteria. Also, tyrosine-43 and lysine-69 residues are part of two distinct highly conserved 
motifs: 42RYA44 and 66YFEKP70 (Fig.  1 and Supplementary Figure S3A online), further suggesting that 
the identified residues could play a functional role.
Because loss of function in ArnTY43C, ArnTK69C, ArnTR254C, and ArnTE493C could also reflect struc-
tural modifications imposed by the non-native cysteine residue, we constructed alanine replacements 
at the same positions. The alanine replacement mutant proteins expressed at wild type levels and they 
also appeared in the membrane fraction (Supplementary Figure S3B online). To investigate whether the 
alanine replacement alters the local conformation of the loop, each residue before alanine-43, -69, -254, 
and -493 in ArnTY43A, ArnTK69A, ArnTR254A, and ArnTE493A proteins was replaced by cysteine. PEGylation 
assays using the resulting proteins with cysteine/alanine replacements (ArnTR42C-Y43A, ArnTE68C-K69A, 
ArnTR253C-R254A, and ArnTD492C-E493A) showed labeling of the neighboring cysteines under non-denaturing 
conditions (Supplementary Figure S3C online). Since the residues next to the alanine replacements are 
also accessible to PEG-mal, we conclude that it would unlikely that the alanine replacements cause dra-
matic changes in the local conformation of the protein at these sites.
To investigate the contribution of the mutated residues to ArnT activity we evaluated the PmB sensi-
tivity of ∆arnT expressing the alanine replacement mutant proteins. The wild type strain producing LPS 
with l-Ara4N was extremely resistant to PmB with a minimal inhibitory concentration (MIC) greater 
than 1,024 μ g ml−1, while the ∆arnT MIC was 0.064 μ g ml−1 (16,000-fold difference)13. MICs for ∆arnT 
expressing ArnTK69R, ArnTR254A and ArnTE493A ranged from 8,000-fold reduction relative to wild type, 
while ∆arnT expressing ArnTK69A and ArnTY43A had the same MIC as ∆arnT (Table 1), indicating that 
these replacements affected ArnT activity. Because alanine is a small amino acid typically used in replace-
ments to prevent structural changes in proteins, we surmise that tyrosine-43, lysine-69, arginine-254 and 
glutamic acid-493 are involved in ArnT function.
Lysine-69, arginine-254, and glutamic acid-493 are charged amino acids. To investigate whether the 
charge or the nature of the amino acid is important for ArnT function we replaced lysine-69 with argi-
nine and glutamic acid, arginine-254 with lysine and glutamic acid, and glutamic acid-493 with aspartic 
acid and lysine. All mutant proteins were detectable in whole cells by immunoblotting (Supplementary 
Figure S3D online). Neither lysine-69 nor arginine-254 replaced with opposite or same-charge amino 
acids resulted in proteins that could restore PmB resistance at MIC values similar to the wild type strain 
(Table 1). In contrast, ArnT containing glutamic acid-493 replaced by aspartic acid restored PmB resist-
ance in ∆arnT at 128 μ g ml−1 (Table 1), while the opposite charge substitution, ArnTE493K, led to a MIC 
of 0.064 μ g ml−1, identical to that of ∆arnT. Together, these data suggest that tyrosine-43 and lysine-69 
are needed for ArnT function, and also that positive and negative charges at position 254 and 493, 
respectively, are required for ArnT activity.
The effect of the amino acid replacement mutants on ArnT function was also evaluated by examining 
the lipid A structure using matrix-assisted laser desorption ionization-time of flight (MALDI-TOF) mass 
spectrometry in the negative ion mode. The mass spectrum from the wild-type sample showed the pres-
ence of l-Ara4N as indicated by the ion peaks corresponding to tetra-acylated lipid A with one l-Ara4N 
in the monophosphate (at m/z 1496.8) and diphosphate (at m/z 1577.5) forms and penta-acylated lipid 
with one and two l-Ara4N (at m/z 1804.6 and m/z 1935.5, respectively) (Fig.  6A), agreeing with the 
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Figure 5. C-terminus of ArnT from S. enterica is located in the periplasm. (a) Immunoblot of total 
membranes isolated from E. coli DH5α containing plasmids expressing ArnTSe cysteine replacements. 
The proteins were separated by SDS-PAGE and immunoblotting was performed using anti-FLAG. ArnTSe-
FLAG-10xHis was used as control. C148A-C149A (CC/AA) was used as a template to generate the cysteine-
substitution in the C-terminal of ArnTSe. (b) PEGylated samples of ArnTSe were prepared and analyzed as 
described in the legend to Fig. 2B. The positions of the molecular mass marker are indicated to the left. 
Asterisks indicate PEGylated ArnTSe forms. ArnTSe aggregates at the top of the western blots are attributed 
to the mild denaturing conditions. (c) Immunoblot of total membranes from E. coli CC118 cells expressing 
FLAG-ArnTSe-PhoA performed with anti-FLAG. (d) Quantification of PhoA activity in CC118 E. coli expressing 
FLAG-ArnTSe-PhoA. Cells were processed as described in the legend to Fig. 4C using the same positive and 
negative controls. The values represent the mean ± SE from three independent experiments.
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reported B. cenocepacia lipid A structure13,31. As expected, these peaks were absent in the ∆arnT lipid A 
spectrum (Fig. 6B and Table 1). Mass spectrometry analysis of lipid A from ∆arnT expressing ArnTY43A, 
ArnTK69A, ArnTK69E, ArnTR254E and ArnTE493K did not reveal any peaks corresponding to glycoforms 
containing l-Ara4N (Table 1 and Supplementary Figure S4 online). Interestingly, l-Ara4N was present 
in ∆arnT-arnBC+containing, ArnTK69R, ArnTR254A, ArnTR254K, ArnTE493A, and ArnTE493D (Fig.  6C-G and 
Table 1). Because MALDI-TOF does not provide quantitative assessments, we interpreted the presence 
of l-Ara4N as a result of reduced but not abolished ArnT enzyme activity. This interpretation agrees 
with the hypersensitivity to PmB of the strain expressing these mutant proteins (Table  1), suggesting 
insufficient amount of lipid A modification to promote wild type levels of resistance to PmB. We there-
fore conclude that tyrosine-43, lysine-69, arginine-254 and glutamic acid-493 residues are important for 
ArnT function.
To better support these conclusions, we employed the conditional B. cenocepacia mutant Prha::arnT, 
which only grows with rhamnose (permissive condition)13. Recombinant plasmids containing ArnTBc 
derivatives were introduced into Prha::arnT and the resulting transformants examined for viability without 
rhamnose in the medium. Recombinant plasmids expressing ArnTR254A, ArnTR254K and ArnTE493D could 
rescue Prha::arnT growth without rhamnose (Supplementary Figure S5 online). In contrast, vector control 
and plasmids containing ArnTK69E, ArnTR254E, ArnTE493K and ArnTE493A, failed to rescue growth under the 
same condition. Bacteria containing ArnTK69A and ArnTK69R had moderate growth. These results agree 
with the lipid A structural analysis. Strains bearing ArnTR254A, ArnTR254K and ArnTE493D had l-Ara4N 
in the LPS, and they could rescue viability in absence of rhamnose. Nevertheless, the MIC value from 
these strains is very similar to ∆arnT-arnBC+ except for the strains with ArnTE493D, which behaves as 
the wild-type strain.
Together, these results indicate that ArnT with substitutions preserving the net charge of each residue 
were slightly functional, while substitutions reversing the charge caused loss of function. Therefore, the 
net charges in lysine-69 and arginine-254 are important for ArnT activity.
Tyrosine-36, lysine-62 and glutamic acid-478 are also important for S. enterica ArnT. An ear-
lier report identified arginine-246 (corresponding arginine-254 of ArnTBc) as being functionally impor-
tant for the S. enterica ArnT23. We investigated whether ArnTSe tyrosine-36, lysine-62, and glutamic 
acid-478 (corresponding to tyrosine-43, lysine-69, and glutamic acid-493 in ArnTBc, respectively) are also 
required for ArnTSe function. However, the ArnTSe-FLAG-10xHis fusion resulted in a protein that could not 
be detected by immunoblot. This could be due to structural constrains associated with a proline at the 
C-terminal end of the protein, which were resolved by replacing proline-547 by alanine without altering 
ArnT function32. Therefore, we constructed a P547A ArnTSe-FLAG-10xHis protein and the corresponding ala-
nine replacements in tyrosine-36, lysine-62, and glutamic acid-478. The recombinant proteins were tested 
for their ability to restore PmB resistance in an E. coli Δ arnT mutant. The complementation experiment 
indicated that these proteins could not confer PmB resistance, suggesting that the mutated residues are 
also important for ArnT activity in S. enterica (Fig. 7A); the stability of these proteins was not affected 
as shown by immunoblotting (Fig.  7B). Therefore, tyrosine-36, lysine-62 and glutamic acid-478 play a 
crucial role in the function of the ArnTSe, demonstrating that the conserved amino acids in ArnTBc are 
also important in other ArnT family proteins.
Residue
MIC (μg 
ml−1)
Fold 
difference
Presence of 
l-Ara4N in 
lipid A
ArnT > 1,024 1 Yes
∆arnT-arnBC+ 0.064 16,000 No
ArnTY43A 0.064 16,000 No
ArnTK69A 0.064 16,000 No
ArnTK69R 0.125 8,192 Yes
ArnTK69E 0.094 10,894 No
ArnTR254A 0.125 8,192 Yes
ArnTR254K 0.064 16,000 Yes
ArnTR254E 0.064 16,000 No
ArnTE493A 0.125 8,192 Yes
ArnTE493D 128 8 Yes
ArnTE493K 0.064 16,000 No
Table 1. PmB MIC values of cells expressing ArnT mutant proteins unable to complement the ∆arnT-
arnBC+ lptGD31H (∆arnT) suppressor mutant. MICs were determined by E-Test. The presence of l-Ara4N in 
the lipid A was determined by MS-MALDI-TOF using the negative ion mode, as described in Methods.
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Figure 6. MALDI-TOF spectra of purified lipid A produced by arnT mutants. ∆arnT denotes strain 
MH55 (∆arnT-arnBC+ lptGS), which carries a lptG suppressor mutation (Table S1). Plasmids encoding ArnT 
proteins with various replacements are introduced into MH55 by triparental mating. The profiles represented 
were obtained using the negative ion mode. I-II Tetra-acylated lipid A with one or two phosphates 
molecules; III-IV, Tetra-acylated lipid A with one or two l-Ara4N molecules. V, Penta-acylated lipid A; VI-
VII, Penta-acylated lipid A with one or two l-Ara4N molecules.
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Discussion
Glycosylation of the lipid A phosphate groups with l-Ara4N, catalyzed by ArnT, is a strategy commonly 
used by bacteria to overcome the action of antimicrobial peptides such as PmB33. However, despite the 
growing number of ArnT homologs found in different bacteria to date very little is known on the mech-
anism of ArnT modification. We report in this work the membrane topology of B. cenocepacia and S. 
enterica ArnT proteins. Application of a topology prediction algorithm in combination with substituted 
cysteine scanning using PEGylation yielded an experimentally validated model for ArnTBc that suggests 
13-transmembrane helices, two large periplasmic hydrophilic loops, and an extended C-terminus also 
located in the periplasm. Comparison of the B. cenocepacia ArnT model with an earlier model of ArnT 
from S. enterica reveals striking differences. Unlike ArnTBc, the proposed ArnTSe model suggested four 
periplasmic loops and placed the C-terminal end towards the cytosol23. Our PEGylation results do not 
support the earlier ArnTSe model since two adjacent cysteines at positions 148 and 149, predicted to face 
the periplasm, were inaccessible to PEG-mal indicating they are buried in the membrane. In the previous 
model23, the ArnTSe C-terminus was also assigned a cytosolic location without any experimental valida-
tion and despite bioinformatic data suggesting the opposite. In contrast, our PEGylation data and a posi-
tive alkaline phosphatase ArnT-PhoA C-terminal fusion strongly support that the C-terminal segment of 
ArnTSe is in the periplasm. We therefore conclude that B. cenocepacia and S. enterica ArnT proteins share 
similar topology, as expected for proteins of the same family performing the same function.
We also identified putative functional residues in ArnTBc that are highly conserved in ArnT proteins 
from different bacteria. These include tyrosine-43, lysine-69, and arginine-254. Furthermore, a negative 
charged amino acid is required at position 493 (glutamic acid in ArnTBc). All these putative functional 
residues reside on the periplasmic side of ArnT, as expected for an enzyme using substrates only avail-
able in the periplasm15,17. We propose that these residues may participate either in catalysis or binding 
of the undecaprenyl-l-Ara4N donor substrate. Tyrosine-43 and lysine-69 residues are within two highly 
conserved motifs in all ArnT family members: 42RYA44 and 66YFEKP70. The conservation of these motifs 
within the first periplasmic loop of ArnTBc suggest not only that they are functionally relevant but more 
importantly, that the members of ArnT family share similar features. Further, replacing tyrosine-43 of the 
RYA motif by alanine or inverting the polarity of the lysine-69 resulted in a nonfunctional protein. It is 
possible that the first periplasmic loop containing two highly conserved motifs could define a putative 
catalytic reaction center conserved in all ArnT proteins. Mutagenesis of the arginine-254 residue residing 
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on the second periplasmic loop resulted in a protein with poor enzymatic activity. Agreeing with this 
conclusion, an arginine from ArnTSe corresponding to ArnTBc arginine-254 was also reported to be 
important for the activity of this enzyme23. Our data also suggest that the ArnTSe second periplasmic 
loop, between amino acids 234 and 256, is required for function, as well as a C-terminal glutamic acid-
493. Replacing this residue by aspartic acid, to maintain the same charge, resulted in a protein retaining 
the ability to incorporate l-Ara4N to lipid A and supports the notion that the ArnT C-terminus is also 
involved in the overall activity of this enzyme. However, our assignment of the functional residues has to 
remain tentative until validation by further biochemical investigations using purified protein, substrates, 
and acceptor molecules.
The mechanism of transfer of l-Ara4N to LPS remains to be elucidated. Superficially, ArnT pro-
teins are analogous to O-antigen ligases and oligosaccharyl transferases. These proteins perform the 
enzymatic reaction on the periplasmic side of the membrane, and involve a metal ion-independent 
inverting glycosyltransfer reaction using undecaprenyl-bisphosphate-linked saccharide precursors34. In 
contrast, bacteriophage-encoded glucosyltransferase proteins, which are responsible for the periplasmic 
transfer of glucose to the LPS O antigen moiety35,36, utilize a lipid phosphate-activated glucosyl residue 
(Und-P-glucose)37. ArnT proteins also utilize undecaprenyl-phosphate-linked saccharides, and the reac-
tion occurs at the periplasmic site of the membrane17. Further, there is an inversion of the stereochemis-
try in the reaction since the substrate is Und-P-α -l-Ara4N17, but l-Ara4N is β -linked to the phosphate 
groups of the lipid A at 4’ and 1 positions31, suggesting ArnT proteins are also inverting glycosyltrans-
ferases. Given these similarities with other glycan ligases, it is reasonable to find that key functional 
residues are located on the periplasmic exposed side of ArnT.
In this work, we demonstrate that ArnT proteins from B. cenocepacia and S. enterica share topology and 
functional residues. In B. cenocepacia, however, l-Ara4N is added to lipid A and the d-glycero-d-talo-octo-
2-ulosonic acid inner core sugar, modifications that confer extremely high resistance to PmB13. In con-
trast, S. enterica and E. coli ArnT transfer l-Ara4N only to lipid A and comparatively these strains present 
much lower levels of PmB resistance31. The topological similarities and functionally conserved residues 
between ArnTBc and ArnTSe suggest that both proteins have more in common that one would expect if 
they had different specificities. However, we cannot exclude the possibility that another region in ArnTBc 
is responsible for specific recognition of the Burkholderia LPS, making this protein different than that of 
E. coli, Salmonella, and other bacteria. Alternatively, a distinct l-Ara4N transferase could be required in 
B. cenocepacia to add l-Ara4N to the inner core d-glycero-d-talo-octo-2-ulosonic acid after ArnT trans-
fers l-Ara4N to the lipid A. Further research is needed to investigate these possibilities and examine the 
sequential process of l-Ara4N incorporation to lipid A and inner core in detail.
In summary, this study provides experimental evidence that ArnT proteins from B. cenocepacia and 
S. enterica, which play key roles in remodeling LPS, share topological and functional similarities that 
also extend to other members of the ArnT family and provide insights for further investigation of ArnT 
proteins and the elucidation of their catalytic mechanism.
Methods
Bacterial strains and growth conditions. Bacterial strains and plasmids are listed in Supplementary 
Table S1 online. Growth medium was supplemented as needed with the following chemicals (final con-
centrations): 100 μ g ampicillin ml−1, 30 μ g chloramphenicol ml−1, 50 μ g trimethoprim ml−1, 25 μ g gen-
tamicin ml−1, 10 μ g PmB ml−1, 0.2% l-arabinose (w/v), and 0.2% l-rhamnose (w/v). Bacteria were grown 
aerobically at 37 °C in Luria-Bertani (LB) medium (Difco). For recombinant protein expression, bacteria 
were grown overnight in 5 mL of LB, diluted to A600 of 0.1, and incubated at 37 °C for 2 h until cultures 
reached A600 of 0.5, at which point l-arabinose was added and cells incubated for 3 h at 37 °C.
Construction of plasmids expressing parental and mutant ArnT proteins. A plasmid encoding 
ArnTFLAG-10xHis was constructed by PCR amplification of a 1.7-kb fragment using B. cenocepacia K56-2 
genomic DNA and primers 6269/6270 (Supplementary Table S2 online). The fragment was digested with 
EcoRI and SalI and ligated into the same sites of pXR134. This plasmid is a modified pBAD24 containing 
an oligonucleotide sequence encoding a FLAG plus 10x-His tag, which was placed adjacent to the mul-
tiple cloning site for construction of in-frame C-terminally FLAG-10xHis-tagged proteins. The resulting 
plasmid, designated pFT1, expressed ArnTFLAG-10xHis under the control of the arabinose-inducible pro-
moter. pFT1 was used as template to replace the native cysteines of ArnT (residues 154 and 176) with 
alanine by sequential site-direct mutagenesis using primers 6238/6239, and 6240/6241 (Supplementary 
Table S2 online). The plasmid encoding the cysteineless ArnTFLAG-10xHis was named pFT7. For sulfhydryl 
labeling experiments, novel cysteines were introduced in pFT7 by PCR using primers containing the 
desired mutations and Pfu AD polymerase (Stratagene). DpnI was added to PCR reactions for overnight 
digestion of parental plasmid DNA at 37 °C. The resulting DNA was introduced into E. coli DH5α by 
CaCl2 transformation. Resulting plasmids were confirmed by sequencing with primers 252, 258 and 6385 
(Supplementary Table S2 online).
Alkaline phosphatase (PhoA) fusions and alkaline phosphatase assay. pFT4 and pFT15, 
expressing FLAGArnTBc-PhoA and FLAGArnTSe-PhoA, respectively, were constructed by PCR amplification of 
a 1.7-kb fragment from pFT1 and pMH494 with 6421/6716 and 7178/7182 primer pairs, respectively 
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(Supplementary Table S2 online). The amplicons were digested with XbaI and SalI and ligated into these 
sites in pAH1830. The ligation mixture was introduced by transformation into E. coli CC118 cells, and 
transformants plated on LB-ampicillin containing 5-bromo-4-chloro-3-indolylphosphate (60 μ g ml−1). 
Transformants were screened for blue colony phenotype denoting PhoA activity. To quantify alkaline 
phosphatase activity, overnight cultures were diluted 1:100 and grown for 4 h at 37 °C in LB ampicil-
lin/0.2% arabinose, harvested, lysed, and assayed as described30.
Cloning and expression of arnT from S. enterica. The S. enterica arnT gene was isolated by ampli-
fication of a 1.6-kb fragment using pMH494 as template and primers 6475/6476. The fragment was 
digested with EcoRI and SalI and ligated into the same sites in pFT1 to replace arnT from B. cenocepacia 
by S. enterica arnT. This construct, named pFT54, expressed ArnTSe with a C-terminal FLAG-10xHis tag, 
and was used to introduce novel cysteines by site-directed mutagenesis. For complementation of E. coli 
∆arnT, alanine replacements were introduced in pFT143 (encoding S. enterica ArnTP547A).
Topological model for ArnT. Two prediction methods were used to analyze the in silico topology 
of ArnT: PolyPhobious38 and TMHMM 2.039. The ArnT models were displayed using TMRPred2D40. 
Multiple-sequence alignments of ArnT homologues were performed with ClustalW (http://www.ebi.
ac.uk/clustalw/).
Complementation of ArnT function in B. cenocepacia. Plasmids expressing the ArnT replace-
ment mutant proteins were subcloned into the NdeI-HindIII site of pSCrhaB2, and the recombinant 
constructs introduced in the ∆arnT-arnBC+suppressor strain by triparental mating41,42. The ability of 
each construct to restore PmB resistance indicated ArnT function. Strains were grown overnight with 
0.4% (w/v) rhamnose (to induce protein expression), diluted to 10−1, 10−2, 10−3, 10−4 and 10−5 and 4 μ l 
of each dilution plated onto LB plates supplemented with 0.4% rhamnose and 10 μ g ml−1 PmB.
Membrane preparations and immunoblotting. Bacterial pellets were resuspended in 50 mM 
Tris-HCl, pH 8.0, with protease inhibitors and lysed at 10, 000 PSI using a cell disruptor (Constant 
Systems, Kennesaw, GA). Cell debris was pelleted by centrifugation at 15,000 × g for 15 min at 4 °C, and 
the clear supernatant was centrifuged at 40,000 × g for 30 min at 4 °C. The pellet, containing total mem-
branes, was suspended 50 mM Tris-HCl, pH 8.0. Protein concentration was determined by the Bradford 
assay (Bio-Rad). Proteins were separated by SDS-PAGE on a 12% or 18% gel (if the experiment included 
detection of HA-SoxY) and transferred to a nitrocellulose membrane. Immunoblots were probed with 
anti-FLAG and anti-HA (Sigma) mouse monoclonal antibodies. Secondary anti- mouse Alexa fluor-680 
IgG antibody (Invitrogen) was used to detect fluorescence using an Odyssey infrared imaging system 
(LI-COR Biosciences).
Sulfhydryl labeling. Cells were cultured in 20 ml of LB broth at 37 °C from an initial OD600 of 0.2 
to an OD600 of 0.5 at which time arabinose was added to a final concentration of 0.2% (w/v) for induc-
tion of ArnTFLAG-10xHis protein expression, and growth continued for 3 h. Bacterial cells were harvested 
by centrifugation at 16,000 × g and washed with HEPES/MgCl2 buffer (50 mM HEPES, pH 6.8; 5 mM 
MgCl2). Cell pellets were resuspended in 0.3 ml of HEPES/MgCl2 buffer and divided in three portion: 
0.1 ml of cell suspension was incubated with 1 mM methoxypolyethylene glycol maleimide (PEG-Mal) 
at room temperature for 1 h with 50 mM EDTA for B. cenocepacia ArnT and 5 mM EDTA for S. enterica 
ArnT; 0.1 ml was treated with 2% SDS prior to labeling, and 0.1 ml was incubated with buffer as control. 
The sulfhydryl labeling reaction was stopped with 45 mM of dithiothreitol for 10 min and mixed with 
3X dye buffer (50 mM Tris-HCl [pH 6.8], 2% SDS, 10% glycerol, and 0.1% bromophenol blue), and 
incubated for 30 min at 45 °C. Mild denaturation conditions were used to optimize ArnT detection, as 
these conditions work best for membrane proteins43. The crude membrane fraction was resuspended 
in 50 μ l of HEPES/ MgCl2 buffer supplemented with protease inhibitors. 25 μ l were labeled with 1 mM 
PEG-Mal at room temperature for 1 h. The reaction was quenched by adding 45 mM of dithiothreitol for 
10 min, and centrifuged at 16,000 × g for 1 min. Pellets were suspended in 50 μ l of HEPES/MgCl2 buffer 
with protease inhibitor. Control samples were incubated with buffer alone. Protein was extracted and 
processed as described above.
Thiol-specific chemical blocking with N-ethylmaleimide (NEM). Cell suspensions in HEPES/
MgCl2 buffer (0.1 ml) were incubated with 5mM N-ethylmaleimide (NEM) for 30 min at room tempera-
ture, and centrifuged at 16,000 × g for 1 min. Pellets were washed twice with 1 ml of iced HEPES/MgCl2 
buffer. The samples were suspended in 200 μ l of HEPES/MgCl2 buffer, and incubated with 2% SDS and 
1 mM PEG-Mal for 1 h at room temperature. Samples were quenched with 45 mM of dithiothreitol for 
10 min. Protein extraction was performed as described above.
MIC determination. The MIC was determined on solid media using PmB E-test strips. Overnight 
cultures, were diluted to an A600 of 0.004 in sterile PBS and used to streak LB agar plates using a sterile 
cotton swab. E-test strips containing PmB were added and plates where incubated for 24 h at 37 °C. MIC 
was defined as the lowest concentration of PmB to show growth inhibition.
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Lipid A isolation and mass spectrometry. L-Ara4N modifications of lipid A were identified by 
mass spectrometry (MS) using matrix-assisted laser desorption/ionization-time of flight (MALDI-TOF). 
Cells were grown overnight in LB medium (100 ml) supplemented with 50-μ g ml−1 trimethoprim and 
0.4% rhamnose. Cultures were centrifuged (10,000 × g), washed twice with phosphate buffer (10 mM 
Na2HPO4, 1.7 mM KH2PO4) and freeze-dried. Lipid A was extracted from lyophilized cells and desalted, 
as previously described44. For MS analysis, dihydroxybenzoic acid (DHB) (Sigma Chemical Col, St. 
Louis, MO) was used as a matrix and prepared to saturation in acetonitrile: 0.1% triflouroacetic acid 
(1:2 v/v). Two-microliters of sample was loaded on the target, dried, and covered by 1 μ l of DHB. The 
target was inserted in a Bruker Autoflex MALDI-TOF spectrometer. Data acquisition and analysis were 
performed using the Flex Analysis software.
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Supplementary figures 
 
FIGURE S1 | Polymyxin B resistant phenotype is restored by ArnTFLAG+10xHis in ∆arnT-arnBC+ carrying 
the lptGD31H suppressor mutation. (a)  The strain ∆arnT-arnBC+1 was transformed with pFT3 encoding 
ArnTFLAG+10xHis under the control of the rhamnose inducible promoter or pSCrhaB2 (vector control). 
K556-2 is the parental strains carrying the wild-type arnT (positive control). 10-fold serial dilutions of the 
transformants were spotted on LB supplemented with 0.4% of rhamnose and 10-µg ml-1 PmB. (b) Total 
membrane preparation from ∆arnT-arnBC+ expressing ArnTFLAG-10xHis and pSCrhaB2 as a vector control. 
Ten µg of protein was analyzed by SDS-PAGE, and the immunoblot was probed with the antibody anti-
FLAG. L, BLUeye prestained protein ladder 
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FIGURE S2 | Protein expression of ArnT cysteine replacement. ArnTFLAG-10xHis cysteine derivatives 
were expressed from the arabinose-inducible vector pBAD24. Twenty µl of total protein preparations 
from DH5α cells were separated by 12% SDS-PAGE and the ArnT mutant proteins detected by 
immunoblot with an anti-FLAG monoclonal antibody. 
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FIGURE S3 | Highly conserved residues of ArnT are required for activity. (a) alignment of partial 
sequences of ArnT from different bacteria showing RYA and YFEKP motifs and highly conserved Y43, 
K69, R254, and E493. (b-d) Immunoblot of ArnT proteins containing replacements in functional residues 
detected anti-FLAG. (c) E. coli DH5α carrying plasmids encoding ArnT cysteine replacements were 
grown to mid-exponential phase and protein expression induced with 0.2% L-arabinose. Cells were 
harvest and resuspend in 0.3 ml of HEPES/MgCl2 buffer. 0.1 ml of cell suspension was incubated with 
buffer alone or 1 mM PEG-mal with or without 2% SDS for 1h at room temperature. Reactions were 
quenched with 45 mM DTT, and proteins were separated by SDS-PAGE and transferred to nitrocellulose 
membrane. ArnT derivatives were detected with anti-FLAG. L, molecular masses of protein standards. 
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FIGURE S4 | MALDI-TOF spectra of purified lipid A produced by arnT mutants that did not present L-
Ara4N molecule. The profiles represented were obtained using the negative ion mode. I-II Tetra-acylated 
lipid A with one or two phosphates molecules. V, Penta-acylated lipid A. 
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FIGURE S5 | arnT mutants cannot rescue growth of B. cenocepacia without L-Ara4N synthesis. 
Plasmids encoding the various ArnT derivatives were introduced into the conditional mutant strain 
Prha::arnT 1. Dilutions were spotted in LB plate with or without 0.4% rhamnose. 
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Supplementary Tables 
 
Table S1 | Strains used in this study. 
Strain or Plasmid Relevant Properties Source or Reference 
Strains   
E. coli   
DH5α F- φ80lacZM15 endA recA hsdR(r-Κ m-Κ) supE thi 
gyrA relA Δ(lacZYA-argF)U169 
Laboratory stock 
∆arnT BL21(DE3) ΔarnT 2 
CC118 Δ(ara leu) Δlac phoA galE galK thi rpsL rpsB 
argE recA 
Laboratory stock 
B. cenocepacia   
K56-2 Parental strain, clinical isolate of the ET12 clone
  
BCRRCa 3 
MH45 K56-2, Prha::arnT 1 
MH55  ∆arnT-arnBC+ lptGD31H, lptG suppressor strain 1 
Plasmids   
pAH01 pBAD vector expressing Flag-Wzx-K367-PhoA 4 
pAH18 pBAD vector inducible with arabinose, encoding 
an N-terminal FLAG and C-terminal for PhoA 
fusion. 
4 
pAH1809 pBAD vector expressing Flag-Wzx-T242-PhoA 4 
pBAD24 Expression vector inducible with arabinose, for C-
terminal FLAG-10xHis fusions, ApR 
5 
pHASoxYZ E. coli tatA promoter controlling expression of P. 
panthotrophus HA-soxY and soxZ in pSU20, CmR 
6 
pMH494 pSCrhaB2-arnTSe Hamad and Valvano, in 
preparation. 
pRK2013 Helper plasmid used for bacterial conjugation; 
KmR 
7 
pSCrhaB2 Expression vector inducible with rhamnose. Broad 
host range replicative vector; TpR 
8 
pFT1 pBAD expressing ArnT-FLAG-10xHis  This study 
pFT3 pSCrhaB2, ArnTFLAG-10xHis This study 
pFT4 pAH18, FLAG-ArnTBc-PhoA This study 
pFT5 pFT1, ArnTC154A This study 
pFT6 pFT1, ArnTC176A This study 
pFT7 pFT1, ArnTCysless This study 
pFT12 pFT3, ArnTC154A This study 
pFT13 pFT3, ArnTC176A This study 
pFT14 pFT3, ArnTCysless  This study 
pFT15 pAH18, FLAG-ArnTSe-PhoA This study 
pFT20 pFT7, ArnTK324C This study 
pFT21 pFT7, ArnTD350C This study 
pFT28 pFT7, ArnTL385C This study 
pFT38 pFT7, ArnTN62C This study 
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pFT39 pFT7, ArnTG87C This study 
pFT40 pFT7, ArnTN239C This study 
pFT41 pFT7, ArnTS321C This study 
pFT46 pFT7, ArnTR380C This study 
pFT47 pFT7, ArnTD439C This study 
pFT48 pFT7, ArnTE493C This study 
pFT52 pFT7, ArnTG264C This study 
pFT54 pBAD, ArnTSe (FLAG-10xHis) This study 
pFT55 pFT7, ArnTR254C This study 
pFT56 pFT7, ArnTQ530C This study 
pFT61 pFT7, ArnTH137C  This study 
pFT62 pFT7, ArnTI288C  This study 
pFT63 pFT7, ArnTW209C  This study 
pFT64 pFT7, ArnTR544C  This study 
pFT70 pFT54,ArnTSe-C148A/C149A This study 
pFT72 pFT7, ArnTN411C  This study 
pFT73 pFT7, ArnTW512C  This study 
pFT76 pFT7, ArnTL35C  This study 
pFT77 pFT7, ArnTK69C  This study 
pFT79 pFT7, ArnTF247C  This study 
pFT80 pFT7, ArnTQ297C  This study 
pFT86 pFT7, ArnTY43C  This study 
pFT87 pFT7, ArnTV106C This study 
pFT92 pFT3, ArnTR254A This study 
pFT93 pFT3, ArnTE493A This study 
pFT94 pFT7, ArnTV332C  This study 
pFT97 pFT7, ArnTI309C This study 
pFT98 pFT7, ArnTT422C  This study 
pFT109 pFT7, ArnTR550C  This study 
pFT110 pFT3, ArnTK69A  This study 
pFT113 pFT7, ArnTL278C  This study 
pFT116 pFT54, ArnTSe-R506C  This study 
pFT117 pFT54, ArnTSe-Q544C  This study 
pFT119 pFT7, ArnTH483C  This study 
pFT120 pFT7, ArnTY468C This study 
pFT121 pFT3, ArnTY43A  This study 
pFT130 pFT3, ArnTR254K This study 
pFT131 pFT3, ArnTR254E This study 
pFT132 pFT3, ArnTE493D This study 
pFT133 pFT3, ArnTE493K This study 
pFT134 pFT54, ArnTSe-E438C This study 
pFT135 pFT54, ArnTSe-D469C This study 
pFT138 pFT3, ArnTK69R This study 
pFT139 pFT3, ArnTK69E This study 
pFT143 pFT54, ArnTSe-P546A This study 
pFT144 pFT143, ArnTSe-Y36A This study 
pFT145 pFT143, ArnTSe-K62A This study 
pFT146 pFT143, ArnTSe-E478A This study 
pFT195 pFT7, ArnTR42C-Y43A This study 
pFT196 pFT7, ArnTE682C-K69A  This study 
pFT197 pFT7, ArnTR253C-R254A  This study 
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pFT198 pFT7, ArnTD492C-E493A  This study 
pFT210 pFT7, ArnTF138C This study 
pFT211 pFT7, ArnTN139C This study 
pFT213 pFT7, ArnTR161C This study 
pFT214 pFT7, ArnTS186C This study 
pFT215 pFT7, ArnTK187C This study 
pFT216 pFT7, ArnTH322C This study 
pFT217 pFT7, ArnTS323C This study 
aB. cenocepacia complex Research and Referral Repository for Canadian CF Clinics. 
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Table 2 | Primers used in this study. 
 
Primer DNA Sequence Restriction site 
252 5'-GATTAGCGGATCCTACCTGA None 
258 5'-GACCGCTTCTGCGTTCTGAT None 
6238 5'-GCGCTGTCGCTCgcgTCGCTGCTGCTCGCGCAG None 
6239 5'-CTGCGCGAGCAGCAGCGAcgcGAGCGACAGCGC None 
6240 5'-GGCTGGATGTGGGCGgcgTGGGCCGCGATGGCG None 
6241 5'-CGCCATCGCGGCCCAcgcCGCCCACATCCAGCC None 
6269 5'-aaagaattcATGAACGATACGCCGTCGAGGC EcoRI 
6270 5'-aaagtcgactcCGATTGCGGTTTCTCGACGATC SalI 
6385 
6421 
6475 
6476 
6716 
5'-CAGCGGAACCCCGAGTTCTTCAAC 
5'-aaagtcgacCGATTGCGGTTTCTCGACGATC 
5'-aaagaattcATGAAATCGATACGCTATTATC 
5'-aaagtcgactcTTTAGGCCGATACTGAATTAAC 
5'-aaatctagagAACGATACGCCGTCGAGGCTAC 
None 
SalI 
EcoRI 
SalI 
XbaI 
7178 5'-aaatctagagAAATCGATACGCTATTATCTGGC XbaI 
7182 5'-	  aaagtcgacTTTAGGCCGATACTGAATTAAC SalI 
Restriction sites are underlined. 
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